Last reviewed · How we verify
NCT06079645
Lichen Sclerosus - Treatment With Triamcinolone Acetonide: Injections (Syringe and Needle) x Micro Injections (MMP Technique)
NA trial testing Infiltration of triamcinolone acetonide (2mg/ml) through syringes and needles in Lichen Sclerosus of External Female Genital Organs in 20 participants. Completed in 14 June 2025.
14 May 2025
Quick facts
| Lead sponsor | Clinica Dermatologica Arbache ltda |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 20 October 2023 |
| Primary completion | 14 May 2025 |
| Estimated completion | 14 June 2025 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- Infiltration of triamcinolone acetonide (2mg/ml) through syringes and needles
- Infiltration of triamcinolone acetonide (40 mg/ml) with needles
Conditions studied
- Lichen Sclerosus of External Female Genital Organs — all drugs for Lichen Sclerosus of External Female Genital Organs →
Sponsor
Clinica Dermatologica Arbache ltda
Who can join
18 and older, female only, with Lichen Sclerosus of External Female Genital Organs. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This research is about a genital disease known as Lichem Sclerosus and Atrophic. It mainly affects women over 18 years of age. The treatment will involve injections of a medicine that contains cortisone, using two different methods: with a syringe and a needle or with a tattoo machine. Before and after treatment, they will see if women feel pain, itching, burning, scratching or difficulty having sexual intercourse.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06079645
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Clinica Dermatologica Arbache ltda trials
Trials by the same sponsor.
- NCT06110377 — MALE HAIR LOSS - Treatment With Dutasteride Mesotherapy x Dutasteride MMP Technique (Injections With Tattoo Machine) · Phase 4 · unknown
- NCT04046679 — Bleomycin Infusion (MMP®) to Repigment Achromic Scars · Phase 4 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06079645 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Clinica Dermatologica Arbache ltda
- Last refreshed: 21 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06079645.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing